Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiaFrail: Glimepiride Hypoglycemia in Frail Elderly T2DM
NCT02484209Phase 3Withdrawn
- Sponsor
- Diabetes Frail
- Start
- Feb 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Diabetes Frail. Planned start Feb 2016; status: withdrawn.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02484209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484209.